Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹1,029.00
Market cap
₹2,160 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
32.5×Sector 47.4×
Promoter holding
63.31%+1.41% QoQ
FII holding
2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:39 IST BSE
Employee Stock Options

Windlas Biotech Employee Stock Options

Windlas Biotech granted 37,000 stock options and units under its ESOP 2023 and Plan 2025 schemes. The grants aim to incentivize and retain eligible employees.

Execution
Vesting over 1-4 years; exercise period of 4 years from vesting